Iraj Asvadi Kermani

822 total citations
57 papers, 647 citations indexed

About

Iraj Asvadi Kermani is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Iraj Asvadi Kermani has authored 57 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 8 papers in Hematology. Recurrent topics in Iraj Asvadi Kermani's work include Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (5 papers) and Cancer survivorship and care (5 papers). Iraj Asvadi Kermani is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (5 papers) and Cancer survivorship and care (5 papers). Iraj Asvadi Kermani collaborates with scholars based in Iran, United States and Kazakhstan. Iraj Asvadi Kermani's co-authors include Roya Dolatkhah, Saeed Dastgiri, Mohammad Hossein Somi, Faris Farassati, Mortaza Bonyadi, Morteza Ghojazadeh, Ali Esfahani, Mohammad Asghari Jafarabadi, Zohreh Sanaat and Babak Hajipour and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Iraj Asvadi Kermani

54 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iraj Asvadi Kermani Iran 13 253 123 113 103 86 57 647
Roya Dolatkhah Iran 15 303 1.2× 106 0.9× 61 0.5× 125 1.2× 125 1.5× 80 864
R. Ramazani Iran 3 324 1.3× 50 0.4× 56 0.5× 95 0.9× 92 1.1× 4 575
Harindra Jayasekara Australia 16 277 1.1× 256 2.1× 155 1.4× 106 1.0× 67 0.8× 47 778
Keun Young Yoo South Korea 16 315 1.2× 108 0.9× 69 0.6× 132 1.3× 117 1.4× 30 857
Jennifer Boehm United States 10 315 1.2× 53 0.4× 86 0.8× 107 1.0× 109 1.3× 18 705
Nancy Reynoso‐Noverón Mexico 14 179 0.7× 61 0.5× 100 0.9× 80 0.8× 65 0.8× 67 716
Enrique Barrios Uruguay 17 338 1.3× 131 1.1× 133 1.2× 238 2.3× 113 1.3× 43 852
Rex B. Mowat United States 14 511 2.0× 150 1.2× 143 1.3× 129 1.3× 124 1.4× 38 887
Glenn O. Allen United States 19 354 1.4× 116 0.9× 100 0.9× 349 3.4× 168 2.0× 59 1.1k
Kumiko Saika Japan 13 325 1.3× 71 0.6× 87 0.8× 124 1.2× 181 2.1× 80 889

Countries citing papers authored by Iraj Asvadi Kermani

Since Specialization
Citations

This map shows the geographic impact of Iraj Asvadi Kermani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iraj Asvadi Kermani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iraj Asvadi Kermani more than expected).

Fields of papers citing papers by Iraj Asvadi Kermani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iraj Asvadi Kermani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iraj Asvadi Kermani. The network helps show where Iraj Asvadi Kermani may publish in the future.

Co-authorship network of co-authors of Iraj Asvadi Kermani

This figure shows the co-authorship network connecting the top 25 collaborators of Iraj Asvadi Kermani. A scholar is included among the top collaborators of Iraj Asvadi Kermani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iraj Asvadi Kermani. Iraj Asvadi Kermani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pirouzpanah, Saeed, Saeed Pirouzpanah, Soltanali Mahboob, et al.. (2019). Effects of cholecalciferol supplementation on serum angiogenic biomarkers in breast cancer patients treated with tamoxifen: A controlled randomized clinical trial. Nutrition. 72. 110656–110656. 12 indexed citations
2.
Dolatkhah, Roya, Mohammad Hossein Somi, Iraj Asvadi Kermani, Faris Farassati, & Saeed Dastgiri. (2017). A novel KRAS gene mutation report in sporadic colorectal cancer, from Northwest of Iran. Clinical Case Reports. 5(3). 338–341. 3 indexed citations
3.
Vahidi, Maryam, Elnaz Asghari, Hossein Ebrahimi, et al.. (2016). Other Side of Breast Cancer: Factors Associated with Caregiver Burden. Asian Nursing Research. 10(3). 201–206. 55 indexed citations
4.
Ghavamzadeh, Ardeshir, et al.. (2015). Medical oncology, history and its future in Iran.. PubMed. 18(11). 799–805. 3 indexed citations
5.
Dolatkhah, Roya, Saeed Dastgiri, Mohammad Hossein Somi, et al.. (2015). KRAS and BRAF mutations in colorectal cancer patients in northwest of Iran.. Journal of Clinical Oncology. 33(15_suppl). e14508–e14508. 1 indexed citations
6.
Rahmani, Azad, et al.. (2014). Effect of Psychoeducation to Spouses on Psychological Needs of Womens with Breast Cancer: a Clinical Trial. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Kolahi, Sousan, et al.. (2014). Comparison of bone mineral density in young patients with breast cancer and healthy women. SHILAP Revista de lepidopterología.
8.
Kermani, Iraj Asvadi, et al.. (2014). Taurine attenuates chemotherapy-induced nausea and vomiting in acute lymphoblastic leukemia. Amino Acids. 47(1). 101–109. 18 indexed citations
9.
Kermani, Iraj Asvadi, et al.. (2013). Prevalence of Oral Human Papilloma Virus in Healthy Individuals in East Azerbaijan Province of Iran. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Dolatkhah, Roya, Ali Esfahani, Iraj Asvadi Kermani, et al.. (2013). Delayed hemolytic transfusion reaction with multiple alloantibody (Anti S, N, K) and a monospecific autoanti-JK b in intermediate β-thalassemia patient in Tabriz. Asian Journal of Transfusion Science. 7(2). 149–149. 7 indexed citations
11.
Sanaat, Zohreh, et al.. (2013). Survival Analysis of Breast Cancer Patients in Northwest Iran. Asian Pacific Journal of Cancer Prevention. 14(1). 39–42. 18 indexed citations
12.
Dolatkhah, Roya, et al.. (2013). Successful Management of Total Knee Replacement in a High Responder Hemophilia Patient With a History of Inhibitor. Iranian Red Crescent Medical Journal. 15(1). 18–20. 2 indexed citations
13.
Kermani, Iraj Asvadi, et al.. (2011). Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer.. PubMed. 12(6). 1381–4. 16 indexed citations
14.
Kermani, Iraj Asvadi, et al.. (2011). Protective effect of pentoxyfilline in renal toxicity after methotrexate administration.. PubMed. 15(9). 1003–9. 55 indexed citations
15.
Kermani, Iraj Asvadi, et al.. (2008). EFFECTS OF SELF CARE PROGRAM ON QUALITY OF LIFE IN PATIENTS WITH ACUTE LEUKEMIA RECEIVING CHEMOTHERAPY. 10(3). 0–0. 7 indexed citations
16.
Kermani, Iraj Asvadi, et al.. (2007). EFFECTS OF CLINICAL, HEMATOLOGICAL AND IMMUNO-PHENOTYPING FACTORS ON PROGNOSIS OF ACUTE PRO MYELOCYTIC LEUKEMIA. Research in Medicine. 31(3). 233–239. 1 indexed citations
17.
Kermani, Iraj Asvadi, et al.. (2006). BLOOD TRANSFUSION ACUTE REACTIONS IN PATIENTS OF SHAHID GHAZI HOSPITAL. Scientific Journal of Iran Blood Transfus Organ. 2(6). 215–220. 1 indexed citations
18.
Dastgiri, Saeed, et al.. (2006). Human leukocyte antigen and esophageal cancer in the northwestern region of Iran. Diseases of the Esophagus. 19(4). 238–240. 4 indexed citations
19.
Kermani, Iraj Asvadi. (2004). Variation of tumor markers in 277 breast cancer cases.. PubMed. 5(3). 291–3. 3 indexed citations
20.
Kermani, Iraj Asvadi. (2002). Immunophenotyping of Acute Leukemia in Northwestern Iran. Iranian journal of medical sciences. 27(3). 136–138. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roya Dolatkhah Breakdown of academic impact, for papers by R. Ramazani Breakdown of academic impact, for papers by Harindra Jayasekara Breakdown of academic impact, for papers by Keun Young Yoo Breakdown of academic impact, for papers by Jennifer Boehm Breakdown of academic impact, for papers by Nancy Reynoso‐Noverón Breakdown of academic impact, for papers by Enrique Barrios Breakdown of academic impact, for papers by Rex B. Mowat Breakdown of academic impact, for papers by Glenn O. Allen Breakdown of academic impact, for papers by Kumiko Saika
Rankless by CCL
2026